{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:55:33Z","timestamp":1786992933436,"version":"build-2736575974"},"reference-count":97,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["F-0003-19620604"],"award-info":[{"award-number":["F-0003-19620604"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006264","name":"RIKEN","doi-asserted-by":"publisher","award":["hp200303"],"award-info":[{"award-number":["hp200303"]}],"id":[{"id":"10.13039\/501100006264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["62\/412,703"],"award-info":[{"award-number":["62\/412,703"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["62\/972,886"],"award-info":[{"award-number":["62\/972,886"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["63\/032,502"],"award-info":[{"award-number":["63\/032,502"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["MSV000087945"],"award-info":[{"award-number":["MSV000087945"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022246","name":"National Supercomputing Centre Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-008352\/OPP1153692"],"award-info":[{"award-number":["INV-008352\/OPP1153692"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000855","name":"University of Birmingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000866","name":"International AIDS Vaccine Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jmb.2021.167332","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:14:17Z","timestamp":1635380057000},"page":"167332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Glycosylation and Serological Reactivity of an Expression-enhanced SARS-CoV-2 Viral Spike Mimetic"],"prefix":"10.1016","volume":"434","author":[{"given":"Himanshi","family":"Chawla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian E.","family":"Jossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian E.","family":"Faustini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdaus","family":"Samsudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel D.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddy L.","family":"Newby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Marcial-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Lamerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Bond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex G.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam F.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Crispin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2021.167332_b0005","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1126\/science.aat9120","article-title":"Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers","volume":"363","author":"Tokatlian","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167332_b0010","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1016\/j.vaccine.2020.03.007","article-title":"Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity","volume":"38","author":"Joe","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2021.167332_b0015","doi-asserted-by":"crossref","first-page":"11312","DOI":"10.1128\/JVI.01123-15","article-title":"Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity","volume":"89","author":"Hyakumura","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2021.167332_b0020","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1128\/JVI.00230-15","article-title":"Glycan Microheterogeneity at the PGT135 Antibody Recognition Site on HIV-1 gp120 Reveals a Molecular Mechanism for Neutralization Resistance","volume":"89","author":"Pritchard","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2021.167332_b0025","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1213256","article-title":"A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield","volume":"334","author":"Pejchal","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167332_b0030","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01432-19","article-title":"N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies","volume":"94","author":"Huang","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2021.167332_b0035","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1128\/JVI.00628-15","article-title":"Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140","volume":"89","author":"Go","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2021.167332_b0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.sbi.2017.03.008","article-title":"Structural principles controlling HIV envelope glycosylation","volume":"44","author":"Behrens","year":"2017","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jmb.2021.167332_b0045","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.str.2020.04.022","article-title":"Networks of HIV-1 Envelope Glycans Maintain Antibody Epitopes in the Face of Glycan Additions and Deletions","volume":"28","author":"Seabright","year":"2020","journal-title":"Structure"},{"key":"10.1016\/j.jmb.2021.167332_b0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10616-005-4537-x","article-title":"Optimisation of the Cellular Metabolism of Glycosylation for Recombinant Proteins Produced by Mammalian Cell Systems","volume":"50","author":"Butler","year":"2006","journal-title":"Cytotechnology"},{"key":"10.1016\/j.jmb.2021.167332_b0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jbiotec.2013.03.019","article-title":"Control of IgG LC:HC ratio in stably transfected CHO cells and study of the impact on expression, aggregation, glycosylation and conformational stability","volume":"165","author":"Ho","year":"2013","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jmb.2021.167332_b0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.copbio.2014.06.010","article-title":"The choice of mammalian cell host and possibilities for glycosylation engineering","volume":"30","author":"Butler","year":"2014","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jmb.2021.167332_b0065","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1073\/pnas.1722627115","article-title":"Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120","volume":"115","author":"Yolitz","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jmb.2021.167332_b0070","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/14789450.2017.1376658","article-title":"Glycosylation profiling to evaluate glycoprotein immunogens against HIV-1","volume":"14","author":"Behrens","year":"2017","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.jmb.2021.167332_b0075","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02428-16","article-title":"Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers","volume":"91","author":"Go","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2021.167332_b0080","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.6505693","article-title":"Carbohydrate dramatically influences immune reactivity of antisera to viral glycoprotein antigens","volume":"226","author":"Alexander","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167332_b0085","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167332_b0090","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167332_b0095","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jmb.2021.167332_b0100","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First Case of 2019 Novel Coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2021.167332_b0105","first-page":"1480","article-title":"Exploitation of glycosylation in enveloped virus pathobiology","volume":"2019","author":"Watanabe","year":"1863","journal-title":"Biochim. Biophys. Acta - Gen. Subj."},{"key":"10.1016\/j.jmb.2021.167332_b0110","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","article-title":"The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex","volume":"77","author":"Bosch","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2021.167332_b0115","series-title":"Adv. Virus Res.","first-page":"93","article-title":"Structural insights into coronavirus entry","author":"Tortorici","year":"2019"},{"key":"10.1016\/j.jmb.2021.167332_b0120","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nature Microbiol."},{"key":"10.1016\/j.jmb.2021.167332_b0125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.abc5902","article-title":"Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability","volume":"369","author":"Brouwer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167332_b0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"584","author":"Ju","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2021.167332_b0135","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.abc7520","article-title":"Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model","volume":"369","author":"Rogers","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167332_b0140","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1126\/science.abd2321","article-title":"Structural basis of a shared antibody response to SARS-CoV-2","volume":"369","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167332_b0145","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.abc2241","article-title":"A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2","volume":"368","author":"Wu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167332_b0150","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.cell.2020.06.025","article-title":"Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies","volume":"182","author":"Barnes","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2021.167332_b0155","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jmb.2021.167332_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241164","article-title":"Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis","volume":"15","author":"Indenbaum","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jmb.2021.167332_b0165","doi-asserted-by":"crossref","first-page":"eabc8413","DOI":"10.1126\/sciimmunol.abc8413","article-title":"The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients","volume":"5","author":"Premkumar","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jmb.2021.167332_b0170","article-title":"SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup","volume":"57","author":"Stadlbauer","year":"2020","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.jmb.2021.167332_b0175","first-page":"imm.13349","article-title":"Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva","volume":"00","author":"Faustini","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.jmb.2021.167332_b0180","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00941-20","article-title":"Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho","volume":"58","author":"Bryan","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jmb.2021.167332_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-76914-5","article-title":"Detection of SARS-CoV-2 antibodies is insufficient for the diagnosis of active or cured COVID-19","volume":"10","author":"Escribano","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmb.2021.167332_b0190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell."},{"key":"10.1016\/j.jmb.2021.167332_b0195","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(20)30788-1","article-title":"Developing antibody tests for SARS-CoV-2","volume":"395","author":"Petherick","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jmb.2021.167332_b0200","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature17200","article-title":"Pre-fusion structure of a human coronavirus spike protein","volume":"531","author":"Kirchdoerfer","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2021.167332_b0205","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jmb.2021.167332_b0210","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/s41467-017-01708-9","article-title":"Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein","volume":"8","author":"Battles","year":"2017","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2021.167332_b0215","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1126\/science.aaf7066","article-title":"Structural basis for membrane anchoring of HIV-1 envelope spike","volume":"353","author":"Dev","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167332_b0220","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.chom.2021.02.002","article-title":"Virus vaccines: proteins prefer prolines","volume":"29","author":"Sanders","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jmb.2021.167332_b0225","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1016\/j.celrep.2020.03.025","article-title":"Structure-Based Design of Prefusion-Stabilized Filovirus Glycoprotein Trimers","volume":"30","author":"Rutten","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.jmb.2021.167332_b0230","doi-asserted-by":"crossref","first-page":"e1003618","DOI":"10.1371\/journal.ppat.1003618","article-title":"A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies","volume":"9","author":"Sanders","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jmb.2021.167332_b0235","doi-asserted-by":"crossref","first-page":"11544","DOI":"10.1038\/ncomms11544","article-title":"Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits","volume":"7","author":"Robinson","year":"2016","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2021.167332_b0240","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.it.2020.03.007","article-title":"Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses","volume":"41","author":"Jiang","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jmb.2021.167332_b0245","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/thoraxjnl-2020-215414","article-title":"SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study","volume":"75","author":"Shields","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.jmb.2021.167332_b0250","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/pai.13504","article-title":"SARS-CoV-2-specific IgG1\/IgG3 but not IgM in children with Pediatric Inflammatory Multi-System Syndrome","volume":"32","author":"Perez-Toledo","year":"2021","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.jmb.2021.167332_b0255","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167332_b0260","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1021\/acs.biochem.1c00279","article-title":"Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation","volume":"60","author":"Allen","year":"2021","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2021.167332_b0265","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/vaccines9050498","article-title":"Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2","volume":"9","author":"Seephetdee","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jmb.2021.167332_b0270","article-title":"Complete protection by a single dose skin patch delivered SARS-CoV-2 spike vaccine","author":"McMillan","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.jmb.2021.167332_b0275","article-title":"Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines","author":"Walls","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.jmb.2021.167332_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2020.166762","article-title":"Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition","volume":"433","author":"Allen","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2021.167332_b0285","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1038\/s41467-020-16567-0","article-title":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation","volume":"11","author":"Watanabe","year":"2020","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2021.167332_b0290","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.cell.2020.09.018","article-title":"Molecular Architecture of the SARS-CoV-2 Virus","volume":"183","author":"Yao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2021.167332_b0295","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1021\/acscentsci.1c00058","article-title":"Assessing Antigen Structural Integrity through Glycosylation Analysis of the SARS-CoV-2 Viral Spike","volume":"7","author":"Brun","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jmb.2021.167332_b0300","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2021.167332_b0305","doi-asserted-by":"crossref","first-page":"18137","DOI":"10.1073\/pnas.0909696106","article-title":"Glycans on influenza hemagglutinin affect receptor binding and immune response","volume":"106","author":"Wang","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jmb.2021.167332_b0310","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1021\/acs.analchem.8b05372","article-title":"Remarkable Structural Diversity of N -Glycan Sulfation on Influenza Vaccines","volume":"91","author":"She","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jmb.2021.167332_b0315","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.chom.2020.08.004","article-title":"Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor","volume":"28","author":"Zhao","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jmb.2021.167332_b0320","article-title":"Assignment of coronavirus spike protein site-specific glycosylation using GlycReSoft","author":"Klein","year":"2020","journal-title":"Biorxiv"},{"key":"10.1016\/j.jmb.2021.167332_b0325","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.celrep.2016.07.074","article-title":"Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies","volume":"16","author":"McCoy","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.jmb.2021.167332_b0330","doi-asserted-by":"crossref","first-page":"13800","DOI":"10.1073\/pnas.1006498107","article-title":"Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens","volume":"107","author":"Doores","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jmb.2021.167332_b0335","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev-biophys-060414-034156","article-title":"Structure and Immune Recognition of the HIV Glycan Shield","volume":"47","author":"Crispin","year":"2018","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.jmb.2021.167332_b0340","doi-asserted-by":"crossref","unstructured":"H.-Y. Huang, H.-Y. Liao, X. Chen, S.-W. Wang, C.-W. Cheng, M. Shahed-Al-Mahmud, T.-H. Chen, J.M. Lo, et al., Impact of glycosylation on a broad-spectrum vaccine against SARS-CoV-2, (n.d.). https:\/\/doi.org\/10.1101\/2021.05.25.445523.","DOI":"10.1101\/2021.05.25.445523"},{"key":"10.1016\/j.jmb.2021.167332_b0345","doi-asserted-by":"crossref","first-page":"7320","DOI":"10.1073\/pnas.1803990115","article-title":"Structure of the Lassa virus glycan shield provides a model for immunological resistance","volume":"115","author":"Watanabe","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jmb.2021.167332_b0350","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.celrep.2016.02.058","article-title":"Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein","volume":"14","author":"Behrens","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.jmb.2021.167332_b0355","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1021\/acscentsci.0c01056","article-title":"Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein","volume":"6","author":"Casalino","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jmb.2021.167332_b0360","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41586-021-03530-2","article-title":"Adjuvanting a subunit COVID-19 vaccine to induce protective immunity","volume":"594","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2021.167332_b0365","article-title":"Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates","author":"Francica","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.jmb.2021.167332_b0370","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03275-y","article-title":"BNT162b vaccines protect rhesus macaques from SARS-CoV-2","volume":"592","author":"Vogel","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2021.167332_b0375","doi-asserted-by":"crossref","unstructured":"K.S. Corbett, B. Flynn, K.E. Foulds, J.R. Francica, S. Boyoglu-Barnum, A.P. Werner, B. Flach, S. O\u2019Connell, et al., Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates, Https:\/\/Doi.Org\/10.1056\/NEJMoa2024671. 383 (2020) 1544\u20131555. https:\/\/doi.org\/10.1056\/NEJMOA2024671.","DOI":"10.1056\/NEJMoa2024671"},{"issue":"10","key":"10.1016\/j.jmb.2021.167332_b0380","first-page":"1","article-title":"Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19","volume":"101","author":"Kuo","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmb.2021.167332_b0385","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nature Med."},{"key":"10.1016\/j.jmb.2021.167332_b0390","first-page":"319","article-title":"Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis","volume":"10","author":"Kontou","year":"2020","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"10.1016\/j.jmb.2021.167332_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2020.100189","article-title":"Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses","volume":"2","author":"Ladner","year":"2021","journal-title":"Cell Reports Med."},{"key":"10.1016\/j.jmb.2021.167332_b0400","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative Protein Modelling by Satisfaction of Spatial Restraints","volume":"234","author":"\u0160ali","year":"1993","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2021.167332_b0405","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.str.2008.03.005","article-title":"Flexible Fitting of Atomic Structures into Electron Microscopy Maps Using Molecular Dynamics","volume":"16","author":"Trabuco","year":"2008","journal-title":"Structure."},{"key":"10.1016\/j.jmb.2021.167332_b0410","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: Visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.jmb.2021.167332_b0415","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD","volume":"26","author":"Phillips","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmb.2021.167332_b0420","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR data","volume":"34","author":"Huang","year":"2013","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmb.2021.167332_b0425","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1074\/jbc.M601174200","article-title":"Solution Structure of the Severe Acute Respiratory Syndrome-Coronavirus Heptad Repeat 2 Domain in the Prefusion State","volume":"281","author":"Hakansson-McReynolds","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2021.167332_b0430","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abd4251","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","volume":"21","author":"Cai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167332_b0435","article-title":"Uncovering cryptic pockets in the SARS-CoV-2 spike glycoprotein","author":"Zuzic","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.jmb.2021.167332_b0440","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/glycob\/cwz003","article-title":"CHARMM-GUI Glycan Modeler for modeling and simulation of carbohydrates and glycoconjugates","volume":"29","author":"Park","year":"2019","journal-title":"Glycobiology"},{"key":"10.1016\/j.jmb.2021.167332_b0445","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrm2330","article-title":"Membrane lipids: where they are and how they behave","volume":"9","author":"van Meer","year":"2008","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jmb.2021.167332_b0450","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1021\/acs.jctc.8b01066","article-title":"CHARMM-GUI Membrane Builder for Complex Biological Membrane Simulations with Glycolipids and Lipoglycans","volume":"15","author":"Lee","year":"2019","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jmb.2021.167332_b0455","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM Simulations Using the CHARMM36 Additive Force Field","volume":"12","author":"Lee","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jmb.2021.167332_b0460","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1103\/PhysRevA.31.1695","article-title":"Canonical dynamics: Equilibrium phase-space distributions","volume":"31","author":"Hoover","year":"1985","journal-title":"Phys. Rev. A"},{"key":"10.1016\/j.jmb.2021.167332_b0465","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/00268978400101201","article-title":"A molecular dynamics method for simulations in the canonical ensemble","volume":"52","author":"Nos\u00e9","year":"1984","journal-title":"Mol. Phys."},{"key":"10.1016\/j.jmb.2021.167332_b0470","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: A new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.jmb.2021.167332_b0475","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmb.2021.167332_b0480","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: A linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comp. Chem."},{"key":"10.1016\/j.jmb.2021.167332_b0485","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283621005696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283621005696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:21:55Z","timestamp":1762669315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283621005696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":97,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0022283621005696"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2021.167332","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycosylation and Serological Reactivity of an Expression-enhanced SARS-CoV-2 Viral Spike Mimetic","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2021.167332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"167332"}}